Genetic Risk Factors for Dementia

The Handbook of Alzheimer's Disease and Other Dementias

Volumn , Issue , 2011, Pages 195-234

  Hollingworth, Paul ^a   Williams, Julie ^a  

^a Cardiff University   (United Kingdom)

Author keywords

AD genetics, two categories; AD, most common form of dementia; Amyloid precursor gene and AD; APOE and vascular dementia; Apolipoprotein E (ApoE) effect; Biological pathways, affecting different dementias; Genetic risk factors for dementia; Late onset Alzheimer's disease; Pathogenesis and disease mechanisms; Vascular dementia

Indexed keywords

EID: 84886710321     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444344110.ch6     Document Type: Chapter

References (240)

1. Abrahamson, M., Grubb, A., Olafsson, I., & Lundwall, A. (1987). Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Letters, 216 (2), 229-233.
2. Arima, K., Kowalska, A., Hasegawa, M., Mukoyama, M., Watanabe, R., Kawai, M., et al. (2000). Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene. Neurology, 54 (9), 1787-1795.
3. Athan, E. S., Lee, J. H., Arriaga, A., Mayeux, R. P., & Tycko, B. (2002). Polymorphisms in the promoter of the human APP gene: Functional evaluation and allele frequencies in Alzheimer disease. Archives of Neurology, 59 (11), 1793-1799.
4. Atwood, L. D., Wolf, P. A., Heard-Costa, N. L., Massaro, J. M., Beiser, A., D'Agostino, R. B., et al. (2004). Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke, 35 (7), 1609-1613.
5. Avramopoulos, D., Fallin, M. D., & Bassett, S. S. (2005). Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms. American Journal of Medical Genetics, B NeuroPsychiatric Genetics, 132 (1), 9-13.
6. Bacanu, S. A., Devlin, B., Chowdari, K. V., DeKosky, S. T., Nimgaonkar, V. L., & Sweet, R. A. (2002). Linkage analysis of Alzheimer disease with psychosis. Neurology, 59 (1), 118-120.
7. Bacanu, S. A., Devlin, B., Chowdari, K. V., DeKosky, S. T., Nimgaonkar, V. L., & Sweet, R. A. (2005). Heritability of psychosis in Alzheimer disease. American Journal of Geriatric Psychiatry, 13 (7), 624-627.
8. Barba, R., Martinez-Espinosa, S., Rodriguez-Garcia, E., Pondal, M., Vivancos, J., & Del Ser, T. (2000). Poststroke dementia: Clinical features and risk factors. Stroke, 31 (7), 1494-1501.
9. Barrett, J. C. & Cardon. L. R. (2006). Evaluating coverage of genome-wide association studies. Nature Genetics, 38 (6), 659-662.
10. Bassett, S. S., Avramopoulos, D., & Fallin, D. (2002). Evidence for parent of origin effect in late-onset Alzheimer disease. American Journal of Medical Genetics, 114 (6), 679-686.
11. Bergem, A. L., Engedal, K., & Kringlen, E. (1997). The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Archives of General Psychiatry, 54 (3), 264-270.
12. Bernardi, L., Maletta, R. G., Tomaino, C., Smirne, N., Di Natale, M., Perri, M., et al. (2006). The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiology of Aging, 27 (5), 702-709.
13. Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., et al. (2000). Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science, 290 (5500), 2302-2303.
14. Bertram, L., Lill, C. M., et al. (2010). The genetics of Alzheimer disease: Back to the future. Neuron, 68 (2), 270.
15. Betard, C., Robitaille, Y., Gee, M., Tiberghien, D., Larrivee, D., Roy, P., et al. (1994). Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport, 5 (15), 1893-1896.
16. Biffi, A., Anderson, C. D., et al. (2010). Genetic variation and neuroimaging measures in Alzheimer disease. Archives of Neurology, 67 (6), 677-685.
17. Bird, T., Knopman, D., Van Swieten, J., Rosso, S., Feldman, H., Tanabe, H., et al. (2003). Epidemiology and genetics of frontotemporal dementia/Pick's disease. Annals of Neurology, 54 (Suppl 5), S29-S31.
18. Blacker, D., Bertram, L., Saunders, A. J., Moscarillo, T. J., Albert, M. S., Wiener, H., et al. (2003). Results of a high-resolution genome screen of 437 Alzheimer's disease families. Human Molecular Genetics, 12 (1), 23-32.
19. Blacker, D., & Lovestone, S. (2006). Genetics and dementia nosology. Journal of Geriatric Psychiatry and Neurology, 19 (3), 186-191.
20. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., et al. (1996). Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron, 17 (5), 1005-1013.
21. Bornebroek, M., Haan, J., Maat-Schieman, M. L., Van Duinen, S. G., & Roos, R. A. (1996). Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D), I-A review of clinical, radiologic and genetic aspects. Brain Pathology, 6 (2), 111-114.
22. Breitner, J. C., Silverman, J. M., Mohs, R. C., & Davis, K. L. (1988). Familial aggregation in Alzheimer's disease: Comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology, 38 (2), 207-212.
23. Breitner, J. C., Welsh, K. A., Gau, B. A., McDonald, W. M., Steffens, D. C., Saunders, A. M., et al. (1995). Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Archives of Neurology, 52 (8), 763-771.
24. Bugiani, O., Murrell, J. R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., et al. (1999). Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. Journal of Neuropathology & Experimental Neurology, 58 (6), 667-677.
25. Bullido, M. J., Artiga, M. J., Recuero, M., Sastre, I., Garcia, M. A., Aldudo, J., et al. (1998). A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genetics, 18 (1), 69-71.
26. Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., et al. (1999). Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. American Journal of Human Genetics, 65 (3), 664-670.
27. Canadian Study of Health and Aging (1994). The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology, 44 (11), 2073-280.
28. Cao, Q., Martinez, M., Zhang, J., Sanders, A. R., Badner, J. A., Cravchik, A., et al. (1997). Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics, 43 (1), 1-8.
29. Carmelli, D., DeCarli, C., Swan, G. E., Jack, L. M., Reed, T., Wolf, P. A., et al. (1998). Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke, 29 (6), 1177-1181.
30. Carrasquillo, M. M., Belbin, O., et al. (2010). Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Archives of Neurology, 67 (8), 961-964.
31. Carter, A. M., Catto, A. J., & Grant, P. J. (1999). Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation, 99 (18), 2423-2426.
32. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., et al. (1992). Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature, 360 (6405), 672-674.
33. Clark, L. N., Poorkaj, P., Wszolek, Z., Geschwind, D. H., Nasreddine, Z. S., Miller, B., et al. (1998). Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proceedings of the National Academy of Sciences USA, 95 (22), 13103-13107.
34. Corder, E. H., Basun, H., Lannfelt, L., Viitanen, M., & Winblad, B. (1996). Attenuation of apolipoprotein E Epsilon4 allele gene dose in late age. Lancet, 347 (9000), 542.
35. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261 (5123), 921-923.
36. Corneveaux, J. J., Myers, A. J., et al. (2010). Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Human Molecular Genetics, 19 (16), 3295-3301.
37. Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., et al. (2006). Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 442 (7105), 920-924.
38. Curtis, D., North, B. V., & Sham, P. C. (2001). A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease. Annals of Human Genetics, 65 (Pt 5), 473-481.
39. Daw, E. W., Payami, H., Nemens, E. J., Nochlin, D., Bird, T. D., Schellenberg, G. D., et al. (2000). The number of trait loci in late-onset Alzheimer disease. American Journal of Human Genetics, 66 (1), 196-204.
40. de Groot, J. C., de Leeuw, F. E., Oudkerk, M., Hofman, A., Jolles, J., & Breteler, M. M. (2001). Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology, 56 (11), 1539-1545.
41. Delisle, M. B., Murrell, J. R., Richardson, R., Trofatter, J. A., Rascol, O., Soulages, X., et al. (1999). A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathologica (Berlin), 98 (1), 62-77.
42. Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006). Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. Journal of the Neurosciences, 26 (35), 9057-9068.
43. Dick, D. M., Foroud, T., Flury, L., Bowman, E. S., Miller, M. J., Rau, N. L., et al. (2003). Genomewide linkage analyses of bipolar disorder: A new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. American Journal of Human Genetics, 73 (1), 107-114.
44. Ducros, A., Nagy, T., Alamowitch, S., Nibbio, A., Joutel, A., Vahedi, K., et al. (1996). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval. American Journal of Human Genetics, 58 (1), 171-181.
45. Eichner, J. E., Dunn, S. T., Perveen, G., Thompson, D. M., Stewart, K. E., & Stroehla, B. C. (2002). Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. American Journal of Epidemiology, 155 (6), 487-495.
46. Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C., Baker, M., Adamson, J., et al. (2000). Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science, 290 (5500), 2303-2304.
47. Evans, D. A., Beckett, L. A., Field, T. S., Feng, L., Albert, M. S., Bennett, D. A., et al. (1997). Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. Journal of the American Medical Association, 277 (10), 822-824.
48. Farrer, L. A., Bowirrat, A., Friedland, R. P., Waraska, K., Korczyn, A. D., & Baldwin, C. T. (2003). Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Human Molecular Genetics, 12 (4), 415-422.
49. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association, 278 (16), 1349-1356.
50. Farrer, L. A., O'Sullivan, D. M., Cupples, L. A., Growdon, J. H., & Myers, R. H. (1989). Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Annals of Neurology, 25 (5), 485-493.
51. Flossmann, E., Schulz, U. G., & Rothwell, P. M. (2004). Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke, 35 (1), 212-227.
52. Forman, M. S., Farmer, J., Johnson, J. K., Clark, C. M., Arnold, S. E., Coslett, H. B., et al. (2006). Frontotemporal dementia: Clinicopathological correlations. Annals of Neurology, 59 (6), 952-962.
53. Foster, N. L., Wilhelmsen, K., Sima, A. A., Jones, M. Z., D'Amato, C. J., & Gilman, S. (1997). Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference Participants. Annals of Neurology, 41 (6), 706-715.
54. Fratiglioni, L., Ahlbom, A., Viitanen, M., & Winblad, B. (1993). Risk factors for late-onset Alzheimer' s disease: A population-based, case-control study. Annals of Neurology, 33 (3), 258-266.
55. Fratiglioni, L., De Ronchi, D., & Aguero-Torres, H. (1999). Worldwide prevalence and incidence of dementia. Drugs, & Aging, 15 (5), 365-375.
56. Gatz, M., Pedersen, N. L., Berg, S., Johansson, B., Johansson, K., Mortimer, J. A., et al. (1997). Heritability for Alzheimer's disease: The study of dementia in Swedish twins. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 52 (2), M117-M125.
57. Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., et al. (2006). Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63 (2), 168-174.
58. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer' s disease. Nature, 349 (6311), 704-706.
59. Goedert, M., Spillantini, M. G., Crowther, R. A., Chen, S. G., Parchi, P., Tabaton, M., et al. (1999). Tau gene mutation in familial progressive subcortical gliosis. Nature Medicine, 5 (4), 454-457.
60. Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989). Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron, 3 (4), 519-526.
61. Goldstein, D. B. (2009). Common genetic variation and human traits. New England Journal of Medicine, 360 (17), 1696-1698.
62. Gretarsdottir, S., Sveinbjornsdottir, S., Jonsson, H. H., Jakobsson, F., Einarsdottir, E., Agnarsson, U., et al. (2002). Localization of a susceptibility gene for common forms of stroke to 5q12. American Journal of Human Genetics, 70 (3), 593-603.
63. Grover, A., England, E., Baker, M., Sahara, N., Adamson, J., Granger, B., et al. (2003). A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy. Experimental Neurology, 184 (1), 131-140.
64. Guyant-Marechal, L., Rovelet-Lecrux, A., Goumidi, L., Cousin, E., Hannequin, D., Raux, G., et al. (2007). Variations in the APP gene promoter region and risk of Alzheimer disease. Neurology, 68 (9), 684-687.
65. Hademenos, G. J., Alberts, M. J., Awad, I., Mayberg, M., Shepard, T., Jagoda, A., et al. (2001). Advances in the genetics of cerebrovascular disease and stroke. Neurology, 56 (8), 997-1008.
66. Hamshere, M. L., Holmans, P. A., Dimitrios Avramopoulos, D., Bassett, S. S., Blacker, D., Bertram, L., et al. (2007). Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer' s Disease. Human Molecular Genetics, 16 (22), 2703-2712.
67. Hardy, J. A., Owen, M. J., Goate, A. M., James, L. A., Haynes, A. R., Rossor, M. N., et al. (1989). Molecular genetics of Alzheimer' s disease. Biochemical Society Transactions, 17 (1), 75-76.
68. Harold, D., Abraham, R., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41 (10), 1088-1093.
69. Hayashi, S., Toyoshima, Y., Hasegawa, M., Umeda, Y., Wakabayashi, K., Tokiguchi, S., et al. (2002). Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Annals of Neurology, 51 (4), 525-530.
70. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003). Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Archives of Neurology, 60 (8), 1119-1122.
71. Hendrie, H. C. (1998). Epidemiology of dementia and Alzheimer' s disease. American Journal of Geriatric Psychiatry, 6 (2 Suppl 1), S3-S18.
72. Herzig, M. C., Winkler, D. T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., et al. (2004). Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nature Neuroscience, 7 (9), 954-960.
73. Heston, L. L., Mastri, A. R., Anderson, V. E., & White, J. (1981). Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Archives of General Psychiatry, 38 (10), 1085-1090.
74. Hirono, N., Yasuda, M., Tanimukai, S., Kitagaki, H., & Mori, E. (2000). Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke, 31 (6), 1263-1268.
75. Hirschhorn, J. N. (2009). Genome-wide Association Studies-Illuminating biologic pathways. New England Journal of Medicine, 360 (17), 1699.
76. Hirschhorn, J. N. & Lettre, G. (2009). Progress in genome-wide association studies of human height. Hormone Research, 71 (Suppl 2), 5-13.
77. Hodges, J. R., & Miller, B. (2001). The neuropsychology of frontal variant frontotemporal dementia and semantic dementia. Introduction to the special topic papers: Part II. Neurocase, 7 (2), 113-121.
78. Hollingworth, P., Hamshere, M. L., et al. (2007). Increased familial risk and genome-wide significant linkage for Alzheimer's disease with psychosis. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B (7), 841-848.
79. Hollingworth, P., Hamshere, M. L., Holmans, P. A., O'Donovan, C., Sims, M. R., Powell, J., et al. (2007). Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. American Journal of Medical Genetics, B NeuroPsychiatric Genetics, 144B (7), 841-848.
80. Hollingworth, P., Harold, D., et al. (2010). Alzheimer's disease genetics: Current knowledge and future challenges. International Journal of Geriatric Psychiatry. Hollingworth, P., Harold, D., et al. (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics, 43 (5), 429-435.
81. Holmans, P., Hamshere, M., Hollingworth, P., Rice, F., Tunstall, N., Jones, S., et al. (2005). Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer' s disease. American Journal of Medical Genetics, B NeuroPsychiatric Genetics, 135 (1), 24-32.
82. Huang, Y. (2006). Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies. Current Opinion in Drug Discovery & Development, 9 (5), 627-641.
83. Huff, F. J., Auerbach, J., Chakravarti, A., & Boller, F. (1988). Risk of dementia in relatives of patients with Alzheimer' s disease. Neurology, 38 (5), 786-790.
84. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., et al. (1998). Association of missense and 5 '-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393 (6686), 702-705.
85. Jones, L., Harold, D., et al. (2010). Genetic evidence for the involvement of lipid metabolism in Alzheimer' s disease. Biochimica et Biophysica Acta, 1801 (8), 754-761.
86. Jones, L., Holmans, P. A., et al. (2010). Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One, 5 (11), e13950.
87. Joutel, A., Andreux, F., Gaulis, S., Domenga, V., Cecillon, M., Battail, N., et al. (2000). The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. Journal of Clinical Investigation, 105 (5), 597-605.
88. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., et al. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383 (6602), 707-710.
89. Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssiere, C., et al. (1997). Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet, 350 (9090), 1511-1515.
90. Kehoe, P., Wavrant-De Vrieze, F., Crook, R., Wu, W. S., Holmans, P., Fenton, I., et al. (1999). A full genome scan for late onset Alzheimer's disease. Human Molecular Genetics, 8 (2), 237-245.
91. Khachaturian, A. S., Corcoran, C. D., Mayer, L. S., Zandi, P. P., & Breitner, J. C. (2004). Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry, 61 (5), 518-524.
92. Kodama, K., Okada, S., Iseki, E., Kowalska, A., Tabira, T., Hosoi, N., et al. (2000). Familial frontotemporal dementia with a P301L tau mutation in Japan. Journal of the Neurological Sciences, 176 (1), 57-64.
93. Kwiatkowski, T. J., Jr., Bosco, D. A., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323 (5918), 1205-1208.
94. Lambert, D., Middle, F., Hamshere, M. L., Segurado, R., Raybould, R., Corvin, A., et al. (2005). Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: Evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Molecular Psychiatry, 10 (9), 831.
95. Lambert, J. C., Araria-Goumidi, L., Myllykangas, L., Ellis, C., Wang, J. C., Bullido, M. J., et al. (2002). Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology, 59 (1), 59-66.
96. Lambert, J. C., Heath, S., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics, 41 (10), 1094-1099.
97. Larsson, J. F., Weissman, M. M., Prusoff, B. A., Caruso, K. A., Merikangas, K. & Pauls, D. (1963). Senile dementia: A clinical, sociomedical and genetic study. Acta Psychiatrica Scandinavica, Suppl. 167, 39.
98. Leblanc, G. G., Meschia, J. F., Stuss, D. T., & Hachinski, V. (2006). Genetics of vascular cognitive impairment: The opportunity and the challenges. Stroke, 37 (1), 248-255.
99. Lee, J. H., Cheng, R., Santana, V., Williamson, J., Lantigua, R., Medrano, M., et al. (2006). Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease. Archives of Neurology, 63 (11), 1591-1598.
100. Lee, J. H., Mayeux, R., Mayo, D., Mo, J., Santana, V., Williamson, J., et al. (2004). Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics. Molecular Psychiatry, 9 (11), 1042-1051.
101. Lee, V. M., Goedert, M., & Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annual Review of Neuroscience, 24, 1121-1159.
102. Lendon, C. L., Ashall, F., & Goate, A. M. (1997). Exploring the etiology of Alzheimer disease using molecular genetics. Journal of the American Medical Association, 277 (10), 825-831.
103. Lendon, C. L., Lynch, T., Norton, J., McKeel, Jr. D. W., Busfield, F., Craddock, N., et al. (1998). Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology, 50 (6), 1546-1555.
104. Lettre, G. & Rioux, J. D. (2008). Autoimmune diseases: Insights from genome-wide association studies. Human Molecular Genetics, 17 (R2), R116-R121.
105. Levinson, D. F., Holmans, P., Straub, R. E., Owen, M. J., Wildenauer, D. B., Gejman, P. V., et al. (2000). Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. American Journal of Human Genetics, 67 (3), 652-663.
106. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., et al. (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science, 248 (4959), 1124-1126.
107. Levy-Lahad, E., Lahad, A., Wijsman, E. M., Bird, T. D., & Schellenberg, G. D. (1995). Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Annals of Neurology, 38 (4), 678-680.
108. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., et al. (1995b). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 269 (5226), 973-977.
109. Li, G., Silverman, J. M., Smith, C. J., Zaccario, M. L., Schmeidler, J., Mohs, R. C., et al. (1995). Age at onset and familial risk in Alzheimer's disease. American Journal of Psychiatry, 152 (3), 424-430.
110. Li, Y. J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., et al. (2002). Age at onset in two common neurodegenerative diseases is genetically controlled. American Journal of Human Genetics, 70 (4), 985-993.
111. Liu, L., Forsell, C., Lilius, L., Axelman, K., Corder, E. H., & Lannfelt, L. (1996). Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families. American Journal of Medical Genetics, 67 (3), 306-311.
112. Lucotte, G., Turpin, J. C., & Landais, P. (1994). Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer' s disease. Annals of Neurology, 36 (4), 681-682.
113. Lunetta, K. L., Erlich, P. M., Cuenco, K. T., Cupples, L. A., Green, R. C., Farrer, L. A., et al. (2007). Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study. Alzheimer Disease and Associated Disorders, 21 (2), 85-91.
114. Maat-Schieman, M. L., van Duinen, S. G., Bornebroek, M., Haan, J., & Roos, R. A. (1996). Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D), II-A review of histopathological aspects. Brain Pathology, 6 (2), 115-120.
115. Mackenzie, I. R., Baker, M., West, G., Woulfe, J., Qadi, N., Gass, J., et al. (2006). A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain, 129 (Pt 4), 853-867.
116. Mackenzie, I. R., Shi, J., Shaw, C., Duplessis, D., Neary, D., Snowden, J. S., et al. (2006). Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathologica (Berlin), 112 (5), 551-559.
117. Markus, H. S., & Alberts, M. J. (2006). Update on genetics of stroke and cerebrovascular disease 2005. Stroke, 37 (2), 288-290.
118. Martin, R. L., Gerteis, G. & Gabrielli, Jr., W. F. (1988). A family-genetic study of dementia of Alzheimer type. Archives of General Psychiatry, 45 (10), 894-900.
119. Martinez, M., Campion, D., Brice, A., Hannequin, D., Dubois, B., Didierjean, O., et al. (1998). Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. Archives of Neurology, 55 (6), 810-816.
120. Martinez, M., Goldin, L. R., Cao, Q., Zhang, J., Sanders, A. R., Nancarrow, D. J., et al. (1999). Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. American Journal of Medical Genetics, 88 (4), 337-343.
121. McCarron, M. O., Muir, K. W., Nicoll, J. A., Stewart, J., Currie, Y., Brown, K., et al. (2000). Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Archives of Neurology, 57 (10), 1480-1484.
122. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s Disease. Neurology, 34 (7), 939-944.
123. McQueen, M. B., Devlin, B., Faraone, S. V., Nimgaonkar, V. L., Sklar, P., Smoller, J. W., et al. (2005). Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. American Journal of Human Genetics, 77 (4), 582-595.
124. Meschia, J. F., Kissela, B. M., Brott, T. G., Brown, Jr., R. D., Worrall, B. B., Beck, J., et al. (2006). The Siblings with Ischemic Stroke Study (SWISS), a progress report. Clinical Medicine & Research, 4 (1), 12-21.
125. Meyer, J. S., Kawamura, J., & Terayama, Y. (1992). White matter lesions in the elderly. Journal of the Neurological Sciences, 110 (1-2), 1-7.
126. Mohlke, K. L., Boehnke, M., et al. (2008). Metabolic and cardiovascular traits: An abundance of recently identified common genetic variants. Human Molecular Genetics, 17 (R2), R102-R108.
127. Morgan, K. (2011). Commentary: The three new pathways leading to Alzheimer's disease. Neuropathology and Applied Neurobiology.
128. Morris, H. R., Khan, M. N., Janssen, J. C., Brown, J. M., Perez-Tur, J., Baker, M., et al. (2001). The genetic and pathological classification of familial frontotemporal dementia. Archives of Neurology, 58 (11), 1813-1816.
129. Mukherjee, O., Kauwe, J. S., Mayo, K., Morris, J. C., & Goate, A. M. (2007). Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. BMC Genetics, 8, 3.
130. Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramic, D., et al. (2000). Susceptibility locus for Alzheimer's disease on chromosome 10. Science, 290 (5500), 2304-2305.
131. Myers, A., Wavrant De-Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., et al. (2002). Full genome screen for Alzheimer disease: Stage II analysis. American Journal of Medical Genetics, 114 (2), 235-244.
132. Myers, A., Kaleem, M., Marlowe, L., Pittman, A. M., Lees, A. J., Fung, H. C., et al. (2005). The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Human Molecular Genetics, 14 (16), 2399-2404.
133. Myers, R. H., Schaefer, E. J., Wilson, P. W., D'Agostino, R., Ordovas, J. M., Espino, A., et al. (1996). Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology, 46 (3), 673-677.
134. Nahed, B. V., Seker, A., Guclu, B., Ozturk, A. K., Finberg, K., Hawkins, A. A., et al. (2005). Mapping a Mendelian form of intracranial aneurysm to 1p34. 3-p36. 13. American Journal of Human Genetics, 76 (1), 172-179.
135. Naj, A. C., Jun, G. et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics, 43 (5), 436-441.
136. Nalbantoglu, J., Gilfix, B. M., Bertrand, P., Robitaille, Y., Gauthier, S., Rosenblatt, D. S., et al. (1994). Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Annals of Neurology, 36 (6), 889-895.
137. Neary, D., Snowden, J., & Mann, D. (2005). Frontotemporal dementia. Lancet Neurology, 4 (11), 771-780.
138. Nee, L. E., Eldridge, R., Sunderland, T., Thomas, C. B., Katz, D., Thompson, K. E., et al. (1987). Dementia of the Alzheimer type: Clinical and family study of 22 twin pairs. Neurology, 37 (3), 359-363.
139. Nicholl, D. J., Greenstone, M. A., Clarke, C. E., Rizzu, P., Crooks, D., Crowe, A., et al. (2003). An English kindred with a novel recessive tauopathy and respiratory failure. Annals of Neurology, 54 (5), 682-686.
140. Nilsson-Ardnor, S., Janunger, T., Wiklund, P. G., Lackovic, K., Nilsson, A. K., Lindgren, P., et al. (2007). Genome-wide linkage scan of common stroke in families from northern Sweden. Stroke, 38 (1), 34-40.
141. Nowotny, P., Simcock, X., Bertelsen, S., Hinrichs, A. L., Kauwe, J. S., Mayo, K., et al. (2007). Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP). American Journal of Medical Genetics, B NeuroPsychiatric Genetics, 144 (4), 469-474.
142. Olson, J. M., Goddard, K. A.,, & Dudek, D. M. (2001). The amyloid precursor protein locus and very-late-onset Alzheimer disease. American Journal of Human Genetics, 69 (4), 895-899.
143. Olson, J. M., Goddard, K. A.,, & Dudek, D. M. (2002). A second locus for very-late-onset Alzheimer disease: A genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. American Journal of Human Genetics, 71 (1), 154-161.
144. Parker, G. R., Cathcart, H. M., Huang, R., Lanham, I. S., Corder, E. H., & Poduslo, S. E. (2005). Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease. Psychiatric Genetics, 15 (4), 271-275.
145. Pato, C. N., Pato, M. T., Kirby, A., Petryshen, T. L., Medeiros, H., Carvalho, C., et al. (2004). Genome-wide scan in Portuguese Island families implicates multiple loci in bipolar disorder: Fine mapping adds support on chromosomes 6 and 11. American Journal of Medical Genetics, 127B (1), 30-34.
146. Pericak-Vance, M. A., Bass, M. P., Yamaoka, L. H., Gaskell, P. C., Scott, W. K., Terwedow, H. A., et al. (1997). Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. Journal of the American Medical Association, 278 (15), 1237-1241.
147. Pericak-Vance, M. A., Grubber, J., Bailey, L. R., Hedges, D., West, S., Santoro, L., et al. (2000). Identification of novel genes in late-onset Alzheimer's disease. Experimental Gerontology, 35 (9-10), 1343-1352.
148. Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., et al. (2005). AD lesions and infarcts in demented and non-demented Japanese-American men. Annals of Neurology, 57 (1), 98-103.
149. Pohjasvaara, T., Erkinjuntti, T., Vataja, R., & Kaste, M. (1997). Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke, 28 (4), 785-792.
150. Pohjasvaara, T., Mantyla, R., Ylikoski, R., Kaste, M., & Erkinjuntti, T. (2000). Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke, 31 (12), 2952-2957.
151. Polvikoski, T., Sulkava, R., Myllykangas, L., Notkola, I. L., Niinisto, L., Verkkoniemi, A., et al. (2001). Prevalence of Alzheimer's disease in very elderly people: A prospective neuropathological study. Neurology, 56 (12), 1690-1696.
152. Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., et al. (1998). Tau is a candidate gene for chromosome 17 frontotemporal dementia. Annals of Neurology, 43 (6), 815-825.
153. Poorkaj, P., Grossman, M., Steinbart, E., Payami, H., Sadovnick, A., Nochlin, D., et al. (2001). Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Archives of Neurology, 58 (3), 383-387.
154. Poorkaj, P., Muma, N. A., Zhukareva, V., Cochran, E. J., Shannon, K. M., Hurtig, H., et al. (2002). An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Annals of Neurology, 52 (4), 511-516.
155. Prakash, N., Hansson, E., Betsholtz, C., Mitsiadis, T., & Lendahl, U. (2002). Mouse Notch 3 expression in the pre-and postnatal brain: Relationship to the stroke and dementia syndrome CADASIL. Experimental Cell Research, 278 (1), 31-44.
156. Price, T. R., Manolio, T. A., Kronmal, R. A., Kittner, S. J., Yue, N. C., Robbins, J., et al. (1997). Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke, 28 (6), 1158-1164.
157. Raber, J., Huang, Y., & Ashford, J. W. (2004). ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiology of Aging, 25 (5), 641-650.
158. Rademakers, R., Cruts, M., Dermaut, B., Sleegers, K., Rosso, S. M., Van den Broeck, M., et al. (2002). Tau negative frontal lobe dementia at 17q21: Significant finemapping of the candidate region to a 4. 8 cM interval. Molecular Psychiatry, 7 (10), 1064-1074.
159. Raiha, I., Kaprio, J., Koskenvuo, M., Rajala, T., & Sourander, L. (1996). Alzheimer' s disease in Finnish twins. Lancet, 347 (9001), 573-578.
160. Reitz, C., Cheng, R. et al. (2011). Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Archives of Neurology, 68 (1), 99.
161. Riekse, R. G., Leverenz, J. B., McCormick, W., Bowen, J. D., Teri, L., Nochlin, D., et al. (2004). Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. Journal of the American Geriatric Society, 52 (9), 1442-1448.
162. Rizzu, P., Van Swieten, J. C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., et al. (1999). High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. American Journal of Human Genetics, 64 (2), 414-421.
163. Rogaeva, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376 (6543), 775-778.
164. Roks, G., Dermaut, B., Heutink, P., Julliams, A., Backhovens, H., Van de Broeck, M., et al. (1999). Mutation screening of the tau gene in patients with early-onset Alzheimer' s disease. Neuroscience Letters, 277 (2), 137-139.
165. Rollinson, S., Mead, S., et al. (2011). Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis. Neurobiology of Aging, 32 (4), 751-758.
166. Roos, Y. B., Pals, G., Struycken, P. M., Rinkel, G. J., Limburg, M., Pronk, J. C., et al. (2004). Genome-wide linkage in a large Dutch consanguineous family maps a locus for intracranial aneurysms to chromosome 2p13. Stroke, 35 (10), 2276-2781.
167. Rosand, J., Bayley, N., Rost, N., & de Bakker, P. I. (2006). Many hypotheses but no replication for the association between PDE4D and stroke. Nature Genetics, 38 (10), 1091-1092 ; author reply 1092-1093.
168. Rosand, J., Hylek, E. M., O'Donnell, H. C., & Greenberg, S. M. (2000). Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology, 55 (7), 947-951.
169. Roses, A. D. (1998). Alzheimer diseases: A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. American Journal of Medical Genetics, 81 (1), 49-57.
170. Roses, A. D., Saunders, A. M., Huang, Y., Strum, J., Weisgraber, K. H., & Mahley, R. W. (2007). Complex disease-associated pharmacogenetics: Drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics Journal, 7 (1), 10-28.
171. Rosso, S. M., Donker Kaat, L., Baks, T., Joosse, M., de Koning, I., Pijnenburg, Y., et al. (2003). Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population-based study. Brain, 126 (Pt 9), 2016-2022.
172. Rosso, S. M., Kamphorst, W., Graaf, B., de Willemsen, R., Ravid, R., Niermeijer, M. F., et al. (2001). Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21- 22. Brain, 124 (Pt 10), 1948-1957.
173. Rosso, S. M., Kamphorst, W., et al. (2001). Familial frontotemporal dementia with ubiquitinpositive inclusions is linked to chromosome 17q21-22. Brain, 124 (Pt 10), 1948-1957.
174. Sabbadini, G., Francia, A., Calandriello, L., Di Biasi, C., Trasimeni, G., Gualdi, G. F., et al. (1995). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain, 118 (Pt 1), 207-215.
175. Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43 (8), 1467-1472.
176. Saunders, A. M., Trowers, M. K., Shimkets, R. A., Blakemore, S., Crowther, D. J., Mansfield, T. A., et al. (2000). The role of apolipoprotein E in Alzheimer's disease: Pharmacogenomic target selection. Biochimica et Biophysica Acta, 1502 (1), 85-94.
177. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., et al. (1993). Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences USA, 90 (20), 9649-9653.
178. Schroder, R., Watts, G. D., Mehta, S. G., Evert, B. O., Broich, P., Fliessbach, K., et al. (2005). Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Annals of Neurology, 57 (3), 457-461.
179. Schumacher, J., Kaneva, R., Jamra, R. A., Diaz, G. O., Ohlraun, S., Milanova, V., et al. (2005). Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. American Journal of Human Genetics, 77 (6), 1102-1111.
180. Scott, W. K., Hauser, E. R., Schmechel, D. E., Welsh-Bohmer, K. A., Small, G. W., Roses, A. D., et al. (2003). Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. American Journal of Human Genetics, 73 (5), 1041-1051.
181. Seshadri, S., Drachman, D. A., & Lippa, C. F. (1995). Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Archives of Neurology, 52 (11), 1074-1079.
182. Seshadri, S., Fitzpatrick, A. L., et al. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease. Journal of the American Medical Association, 303 (18), 1832-1840.
183. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., et al. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375 (6534), 754-760.
184. Sillen, A., Forsell, C., Lilius, L., Axelman, K., Bjork, B. F., Onkamo, P., et al. (2006). Genome scan on Swedish Alzheimer's disease families. Molecular Psychiatry, 11 (2), 182-186.
185. Silverman, J. M., Ciresi, G., Smith, C. J., Marin, D. B., & Schnaider-Beeri, M. (2005). Variability of familial risk of Alzheimer disease across the late life span. Archives of General Psychiatry, 62 (5), 565-573.
186. Silverman, J. M., Smith, C. J., Marin, D. B., Mohs, R. C., & Propper, C. B. (2003). Familial patterns of risk in very late-onset Alzheimer disease. Archives of General Psychiatry, 60 (2), 190-197.
187. Sisodia, S. S., & St George-Hyslop, P. H. (2002). Gamma-secretase, Notch, Abeta and Alzheimer's disease: Where do the presenilins fit in ? Nature Reviews Neuroscience, 3 (4), 281-290.
188. Sjogren, T., Sjogren, H. & Lindgren, A. G. (1952). Morbus Alzheimer and morbus Pick: A genetic, clinical and patho-anatomical study. Acta Psychiatrica Scandinavica, Suppl. 82, 1-152.
189. Skoog, I., Hesse, C., Aevarsson, O., Landahl, S., Wahlstrom, J., Fredman, P., et al. (1998). A population study of apoE genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality. Journal of Neurology, Neurosurgery & Psychiatry, 64 (1), 37-43.
190. Sleegers, K., Roks, G., Theuns, J., Aulchenko, Y. S., Rademakers, R., Cruts, M., et al. (2004). Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain, 127 (Pt 7), 1641-1649.
191. Slooter, A. J., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M. M., Van Broeckhoven, C., et al. (1998). Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study. Archives of Neurology, 55 (7), 964-968.
192. Slooter, A. J., Tang, M. X., van Duijn, C. M., Stern, Y., Ott, A., Bell, K., et al. (1997). Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. Journal of the American Medical Association, 277 (10), 818-821.
193. Snowdon, D. A., Greiner, L. H., Mortimer, J. A., Riley, K. P., Greiner, P. A., & Markesbery, W. R. (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Journal of the American Medical Association, 277 (10), 813-817.
194. Song, Y., Stampfer, M. J., & Liu, S. (2004). Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Annals of Internal Medicine, 141 (2), 137-147.
195. Song, Y., Rogaeva, E., Premkumar, S., Brindle, N., Kawarai, T., Orlacchio, A., et al. (1998). Absence of association between Alzheimer disease and the-491 regulatory region polymorphism of APOE. Neuroscience Letters, 250 (3), 189-192.
196. Sperfeld, A. D., Collatz, M. B., Baier, H., Palmbach, M., Storch, A., Schwarz, J., et al. (1999). FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Annals of Neurology, 46 (5), 708-715.
197. Spillantini, M. G., Bird, T. D., & Ghetti, B. (1998). Frontotemporal dementia and parkinsonism linked to chromosome 17: A new group of tauopathies. Brain Pathology, 8 (2), 387-402.
198. Spillantini, M. G., Goedert, M., Crowther, R. A., Murrell, J. R., Farlow, M. R., & Ghetti, B. (1997). Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proceedings of the National Academy of Sciences USA, 94 (8), 4113-4118.
199. Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences USA, 95 (13), 7737-7741.
200. Steffens, D. C., Plassman, B. L., Helms, M. J., Welsh-Bohmer, K. A., Newman, T. T., & Breitner, J. C. (2000). APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives. Neurology, 54 (3), 593-598.
201. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., et al. (1993). Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences USA, 90 (17), 8098-8102.
202. Sudlow, C., Martinez Gonzalez, N. A., Kim, J., & Clark, C. (2006). Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke, 37 (2), 364-370.
203. Sundquist, K., Li, X., & Hemminki, K. (2006). Familial risk of ischemic and hemorrhagic stroke: A large-scale study of the Swedish population. Stroke, 37 (7), 1668.
204. Suzuki, T., Oishi, M., Marshak, D. R., Czernik, A. J., Nairn, A. C.,, & Greengard, P. (1994). Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO Journal, 13 (5), 1114.
205. Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J. C., & Goate, A. (1994). Protection against Alzheimer's disease with apoE epsilon 2. Lancet, 343 (8910), 1432.
206. Teasdale, G. M., Wardlaw, J. M., White, P. M., Murray, G., Teasdale, E. M., & Easton, V. (2005). The familial risk of subarachnoid haemorrhage. Brain, 128 (Pt 7), 1677-1685.
207. Theuns, J., Brouwers, N., Engelborghs, S., Sleegers, K., Bogaerts, V., Corsmit, E., et al. (2006). Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. American Journal of Human Genetics, 78 (6), 936.
208. Theuns, J., & Van Broeckhoven, C. (2000). Transcriptional regulation of Alzheimer' s disease genes: Implications for susceptibility. Human Molecular Genetics, 9 (16), 2383-2394.
209. Tolnay, M., & Probst, A. (2002). Frontotemporal lobar degeneration-Tau as a pied piper? Neurogenetics, 4 (2), 63-75.
210. Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., et al. (1993). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nature Genetics, 3 (3), 256-259.
211. Van Broeckhoven, C., Haan, J., Bakker, E., Hardy, J. A., Van Hul, A., Wehnert, A., et al. (1990). Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science, 248 (4959), 1120-1122.
212. Van Deerlin, V. M., Sleiman, P. M., et al. (2010). Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nature Genetics, 42 (3), 234-239.
213. van der Net, J. B., Janssens, A. C., et al. (2009). Value of genetic profiling for the prediction of coronary heart disease. American Heart Journal, 158 (1), 105.
214. van der Zee, J. & Van Broeckhoven, C. (2011). TMEM106B: A novel risk factor for frontotemporal lobar degeneration. Journal of Molecular Neuroscience.
215. van der Zee, J., Van Langenhove, T., et al. (2011). TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain, 134 (Pt 3), 808-815.
216. van Duijn, C. M., Clayton, D., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., et al. (1991). Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. International Journal of Epidemiology, 20, S13-S20.
217. van Duinen, S. G., Castano, E. M., Prelli, F., Bots, G. T., Luyendijk, W., & Frangione, B. (1987). Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proceedings of the National Academy of Sciences USA, 84 (16), 5991-5994.
218. van Herpen, E., Rosso, S. M., Serverijnen, L. A., Yoshida, H., Breedveld, G., van de Graaf, R., et al. (2003). Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Annals of Neurology, 54 (5), 573-581.
219. van Rijn, M. J., Slooter, A. J., Schut, A. F., Isaacs, A., Aulchenko, Y. S., Snijders, P. J., et al. (2005). Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population. Neurology, 65 (8), 1203-1209.
220. van Swieten, J., & Spillantini, M. G. (2007). Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathology, 17 (1), 63.
221. van Swieten, J. C., Bronner, I. F., Azmani, A., Severijnen, L. A., Kamphorst, W., Ravid, R., et al. (2007). The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo. Journal of Neuropathology & Experimental Neurology, 66 (1), 17-25.
222. van Swieten, J. C., M. Stevens, S. M. Rosso, P. Rizzu, M. Joosse, I. de Koning, et al. (1999). Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Annals of Neurology, 46 (4), 617-626.
223. Venken, T., Claes, S., Sluijs, S., Paterson, A. D., van Duijn, C., Adolfsson, R., et al. (2005). Genomewide scan for affective disorder susceptibility loci in families of a northern Swedish isolated population. American Journal of Human Genetics, 76 (2), 237-248.
224. Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. (2003). Silent brain infarcts and the risk of dementia and cognitive decline. New England Journal of Medicine, 348 (13), 1215-1222.
225. Verpillat, P., Camuzat, A., Hannequin, D., Thomas-Anterion, C., Puel, M., Belliard, S., et al. (2002). Association between the extended tau haplotype and frontotemporal dementia. Archives of Neurology, 59 (6), 935-939.
226. Wang, J. C., Kwon, J. M., Shah, P., Morris, J. C., & Goate, A. (2000). Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology, 55 (11), 1644-1649.
227. Wang, W. Y., Barratt, B. J., et al. (2005). Genome-wide association studies: theoretical and practical concerns. Nature Review Genetics, 6 (2), 109.
228. Watts, G. D., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., et al. (2004). Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nature Genetics, 36 (4), 377-381.
229. Wetterling, T., Kanitz, R. D., & Borgis, K. J. (1996). Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke, 27 (1), 30-36.
230. White, L., Petrovitch, H., Hardman, J., Nelson, J., Davis, D. G., Ross, G. W., et al. (2002). Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Annals of the New York Academy of Sciences, 977, 9-23.
231. Wiklund, P. G., Brown, W. M., Brott, T. G., Stegmayr, B., Brown, Jr., R. D., Nilsson-Ardnor, S., et al. (2007). Lack of aggregation of ischemic stroke subtypes within affected sibling pairs. Neurology, 68 (6), 427-431.
232. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999). Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature, 398 (6727), 513-517.
233. Woo, D., Sauerbeck, L. R., Kissela, B. M., Khoury, J. C., Szaflarski, J. P., Gebel, J., et al. (2002). Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study. Stroke, 33 (5), 1190-1195.
234. Wragg, M., Hutton, M., & Talbot, C. (1996). Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer' s disease. Alzheimer' s Disease Collaborative Group. Lancet, 347 (9000), 509-512.
235. Wu, Z., Kinslow, C., Pettigrew, K. D., Rapoport, S. I., & Schapiro, M. B. (1998). Role of familial factors in late-onset Alzheimer disease as a function of age. Alzheimer Disease and Associated Disorders, 12 (3), 190-197.
236. Yamada, S., Utsunomiya, M., Inoue, K., Nozaki, K., Inoue, S., Takenaka, K., et al. (2004). Genome-wide scan for Japanese familial intracranial aneurysms: Linkage to several chromosomal regions. Circulation, 110 (24), 3727-3733.
237. Yasuda, M., Kawamata, T., Komure, O., Kuno, S., D'Souza, I., Poorkaj, P., et al. (1999). A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology, 53 (4), 864-868.
238. Zabetian, C. P., Hutter, C. M., Factor, S. A., Nutt, J. G., Higgins, D. S., Griffith, A., et al. (2007). Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology, 62 (2), 137-144.
239. Zhang, J., Song, Y., Chen, H., & Fan, D. (2005). The tau gene haplotype h1 confers a susceptibility to Parkinson's disease. European Neurology, 53 (1), 15.
240. Zubenko, G. S., Huff, F. J., Beyer, J., Auerbach, J., & Teply, I. (1988). Familial risk of dementia associated with a biologic subtype of Alzheimer's disease. Archives of General Psychiatry, 45 (10), 889-893.